Louis Edward Tamayo insider trades

Open-market stock purchases and sales by Louis Edward Tamayo, Chief Financial Officer at Lexeo Therapeutics, Inc, from SEC Form 4 filings since Aug 29, 2025.

Recent trades

DateStockTradeValue
Sep 24, 2026LXEO Lexeo Therapeutics, IncBought (not open market)—
Aug 18, 2026LXEO Lexeo Therapeutics, IncSold$20.2K
Jul 1, 2026LXEO Lexeo Therapeutics, IncSold$20.8K
Jun 29, 2026LXEO Lexeo Therapeutics, IncBought (not open market)—
Feb 4, 2026LXEO Lexeo Therapeutics, IncBought (not open market)—
Feb 4, 2026LXEO Lexeo Therapeutics, IncBought (not open market)—

Companies traded

  • LXEO Lexeo Therapeutics, Inc: 2 sales, last Sep 24, 2026

Get free alerts when Louis Edward Tamayo files a new trade →